Jove
Visualize
Contact Us

Related Experiment Videos

The regulatory challenge.

P K Lunde

    Medical Toxicology
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Establishing effective drug regulation requires a national health policy and a comprehensive drug and therapeutic audit. Integrating diverse stakeholder interests remains a significant challenge for global drug use improvement.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Myofiber structure, sarcoplasmic reticulum Ca<sup>2+</sup> handling, and contractile function after muscle-damaging exercise in humans.

    Physiological reports·2025
    Same author

    Intrinsic skeletal muscle alterations in chronic heart failure patients: a disease-specific myopathy or a result of deconditioning?

    Heart failure reviews·2011
    Same author

    Preserved metabolic reserve capacity in skeletal muscle of post-infarction heart failure patients.

    Scandinavian journal of medicine & science in sports·2010
    Same author

    Temperature-dependent skeletal muscle dysfunction in rats with congestive heart failure.

    Journal of applied physiology (Bethesda, Md. : 1985)·2005
    Same author

    Muscle dysfunction during exercise of a single skeletal muscle in rats with congestive heart failure is not associated with reduced muscle blood supply.

    Acta physiologica Scandinavica·2004
    Same author

    Surgical manipulation, but not moderate exercise, is associated with increased cytokine mRNA expression in the rat soleus muscle.

    Acta physiologica Scandinavica·2002
    Same journal

    Chronic low-level lead exposure. Its role in the pathogenesis of hypertension.

    Medical toxicology·1987
    Same journal

    Adverse cardiovascular effects of sulphonylurea drugs. Clinical significance.

    Medical toxicology·1987
    Same journal

    Adverse reactions with oral and parenteral gold preparations.

    Medical toxicology·1987
    Same journal

    Aetiology and treatment of neuroleptic malignant syndrome.

    Medical toxicology·1987
    Same journal

    Aspirin and Reye's syndrome. A reappraisal.

    Medical toxicology·1987
    Same journal

    Focal motor status epilepticus following treatment with azlocillin and cefotaxime.

    Medical toxicology·1987
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    Area of Science:

    • Public Health
    • Health Policy
    • Pharmaceutical Regulation

    Background:

    • Drug regulation should align with national health policies, local needs, and economic factors.
    • A key challenge is developing a comprehensive drug and therapeutic audit for informed decision-making.
    • Existing solutions are fragmented, highlighting the need for better integration.

    Purpose of the Study:

    • To outline the essential components of effective drug regulation.
    • To identify the long-term challenges in establishing a functional drug and therapeutic audit.
    • To explore strategies for integrating diverse stakeholder interests in drug policy.

    Main Methods:

    • Conceptual framework development for drug and therapeutic audits.
    • Analysis of existing international and national drug regulatory efforts.

    Related Experiment Videos

  • Identification of conflicting interests among stakeholders (politicians, industry, consumers).

    • Main Results:

    • Drug regulation necessitates a foundation in national health policy and local context.
    • A three-phase drug and therapeutic audit (data collection, analysis, decision-making) is proposed.
    • Significant challenges exist in balancing sociomedical and economic requirements and integrating stakeholder interests.

    Conclusions:

    • Effective drug regulation requires a clear national policy and a robust therapeutic audit.
    • Addressing political and economic factors is crucial for improving global drug use.
    • Enhanced collaboration, communication, and professional judgment are essential for success.